X

Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
NIH Human Embryonic Stem Cell Registry - Research Using These Lines is Eligible for NIH Funding

NIH Human Embryonic Stem Cell Registry
Research Using This Line is Eligible for NIH Funding

Detailed information for selected cell line:

Cell Line: CSES21; abnormal karyotype
NIH Registration Number: 0118
NIH Approval Number: NIHhESC-11-0118
Available for Distribution: Other - Unknown at this time
Provider Restrictions: HESC recipients must provide documentation of ESCRO, IRB or equivalent ethical review for the research planned with the requested cell lines.

NIH Restrictions: (No Additional Restrictions)
Additional Information: The karyotype for this cell line is 47,XX,+21 (20).

Submitting Organization: Cedars-Sinai Medical Center
Provider Name: Dhruv Sareen, Ph.D.
Provider Phone: (310) 423-7074
Provider Email: ipsccore@cshs.org
Provider URL: http://cedars-sinai.edu/Research/Research-Cores/Induced-Pluripotent-Stem-Cell-Core-/index.aspx
Approval Date: 06/10/2011


View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

  • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on July 13, 2011 
Content Manager: hescregistry@mail.nih.gov 
Technical Issues: E-mail OER Webmaster